Mesoblast Limited

Announcements / Press Releases

2014-December-31	Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
2014-December-17	Key Mesoblast Patent Claims Upheld in Europe (in PDF)
2014-December-4	Release of Shares from Voluntary Escrow (in PDF)
2014-November-26	Appendix 3B - New Issue Announcement, Application for Quotation of Additional Securities and Agreement (in PDF)
2014-November-26	Appendix 3Y - Change of Director's Interest Notice - Mr. Brian Jamieson (in PDF)
2014-November-25	Results of Annual General Meeting Held 25 November 2014 (in PDF)
2014-November-25	2014 Annual General Meeting Chairman's Address (in PDF)
2014-November-25	Japanese Legislation Takes Effect for Expedited Approvals of Regenerative Medical Products (in PDF)
2014-November-13	Mesoblast's Phase 2 Trial Results in Chronic Low Back Pain Presented at North American Spine Society Annual Meeting (in PDF)
2014-October-31	Appendix 4C - Quarterly (in PDF)
2014-October-29	Release of Shares from Voluntary Escrow (in PDF)
2014-October-29	Appendix 3Y - Change of Director's Interest Notice - Mr. Brian Jamieson (in PDF)
2014-October-23	Notice of Annual General Meeting and Explanatory Memorandum (in PDF)
2014-October-1	Mesoblast Partner JCR Pharmaceuticals Files for Marketing Approval of the First Allogeneic Stem Cell Product in Japan (in PDF)
2014-September-26	Appendix 3B (in PDF)
2014-August-29	Change of Company Secretary (in PDF)
2014-August-26	Preliminary Final Report for the Year Ended 30 June 2014 (in PDF)
2014-August-26	Appendix 4E - Preliminary Final Report Year Ending on 30 June 2014 (in PDF)
2014-August-26	Mesoblast Unveils Path to Bring Its Key Products to Market (in PDF)
2014-August-25	Pharmaceutical Executive Joins Mesoblast as Chief Financial Officer (in PDF)
2014-August-22	Appendix 3Y - Change of Director's Interest Notice - Brian Jamieson (in PDF)
2014-August-22	Appendix 3B (in PDF)
2014-August-7	MSB & NIH Agree 120 Patient Trial in End-stage Heart Failure (in PDF)
2014-July-31	Appendix 4C - Quarterly (in PDF)
2014-July-15	Appendix 3B (in PDF)
2014-June-25	Circulation Publishes Improved Outcomes with Mesoblast Cells (in PDF)
2014-June-24	Appendix 3B (in PDF)
2014-June-20	Details of Company Address (in PDF)
2014-June-19	Type 2 Diabetes Results Presented by Study Investigators (in PDF)
2014-June-16	Mesoblast Receives $5.05m for Stem Cell Pipeline Development (in PDF)
2014-June-6	Response to ASX Price Query (in PDF)
2014-May-28	MSB Accelerates Plans for Commercial Manufacturing Operation (in PDF)
2014-May-2	Appendix 3B (in PDF)
2014-April-30	Appendix 3B (in PDF)
2014-April-30	Appendix 4C - Quarterly (in PDF)
2014-April-29	Mesoblast Provides Update on Clinical Programs of Prochymal (in PDF)
2014-April-8	Response to ASX Price Query (in PDF)
2014-March-12	Initial Director's Interest Notice - Mr. William Burns (in PDF)
2014-March-11	Key Pharmaceutical Executive Joins Mesoblast (in PDF)
2014-March-6	Former Roche Pharmaceuticals CEO Joins Mesoblast Board of Directors (in PDF)
2014-February-26	Mesoblast Reports Strong Half-Year Financial Results (in PDF)
2014-February-26	Appendix 4D - Half Year Report for the Six Months to 31 December 2013 (in PDF)
2014-February-26	Half Year Report - 31 December 2013 (in PDF)
2014-February-20	Key European Patent Granted for Mesoblast's MPCs (in PDF)
2014-February-3	Boardroom Radio Interview with Mesoblast Chief Executive (in PDF)
2014-February-3	Change in Substantial Holding (in PDF)
2014-January-31	Appendix 4C - Quarterly (in PDF)
2014-January-30	Positive Disc Repair Results Using Mesoblast Stem Cells (in PDF)
2017	2017 Announcements / Press Releases
2016	2016 Announcements / Press Releases
2015	2015 Announcements / Press Releases
2013	2013 Announcements / Press Releases
2012	2012 Announcements / Press Releases
2011	2011 Announcements / Press Releases
2010	2010 Announcements / Press Releases
2009	2009 Announcements / Press Releases
2008	2008 Announcements / Press Releases
2007	2007 Announcements / Press Releases